David Stegner

5.2k total citations
98 papers, 3.3k citations indexed

About

David Stegner is a scholar working on Hematology, Cardiology and Cardiovascular Medicine and Molecular Biology. According to data from OpenAlex, David Stegner has authored 98 papers receiving a total of 3.3k indexed citations (citations by other indexed papers that have themselves been cited), including 53 papers in Hematology, 22 papers in Cardiology and Cardiovascular Medicine and 19 papers in Molecular Biology. Recurrent topics in David Stegner's work include Platelet Disorders and Treatments (48 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers) and Cell Adhesion Molecules Research (15 papers). David Stegner is often cited by papers focused on Platelet Disorders and Treatments (48 papers), Antiplatelet Therapy and Cardiovascular Diseases (18 papers) and Cell Adhesion Molecules Research (15 papers). David Stegner collaborates with scholars based in Germany, United States and United Kingdom. David Stegner's co-authors include Bernhard Nieswandt, Guido Stoll, Attila Braun, Christoph Kleinschnitz, Michael K. Schuhmann, Sebastian Dütting, Sven G. Meuth, Peter Kraft, Alejandro Berna‐Erro and Robert Kraft and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Investigation and Nature Medicine.

In The Last Decade

David Stegner

91 papers receiving 3.3k citations

Peers

Countries citing papers authored by David Stegner

Since Specialization

Citations

This map shows the geographic impact of David Stegner's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Stegner with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Stegner more than expected).

Fields of papers citing papers by David Stegner

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Stegner. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Stegner. The network helps show where David Stegner may publish in the future.

Co-authorship network of co-authors of David Stegner

This figure shows the co-authorship network connecting the top 25 collaborators of David Stegner. A scholar is included among the top collaborators of David Stegner based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Stegner. David Stegner is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Blocking microglial reactivity via purinergic receptors prevents subacute cognitive deficits after TIA 2026 ·EMBO Molecular Medicine ·Gemma Llovera, Steffanie Heindl, Dániel Péter Varga, Nikolett Lénárt, (unknown), (unknown), David Stegner, Raphael Escaig, Leo Nicolai, Nicolai Franzmeier, Felix Meissner, Ádám Dénes, (unknown)	0
2	Neutrophil recruitment depends on platelet-derived leukotriene B4 2025 ·Blood Advances ·(unknown), (unknown), Carina Gross, (unknown), Philipp Burkard, Nicholas J. Gross, Robert Ahrends, Tamara Girbl, David Stegner	0
3	Dense but not alpha granules of platelets are required for insulin secretion from pancreatic β cells 2024 ·Biochemical and Biophysical Research Communications ·Katarzyna Kolczyńska, (unknown), (unknown), (unknown), (unknown), David Stegner, Grzegorz Sumara	0
4	Soluble Glycoprotein VI Levels Assessed Locally within the Extra- and Intracerebral Circulation in Hyper-Acute Thromboembolic Stroke: A Pilot Study 2024 ·Biomedicines ·(unknown), Alexander M. Kollikowski, (unknown), Guido Stoll, Bernhard Nieswandt, Mirko Pham, David Stegner, Michael K. Schuhmann	0
5	The bone marrow is the primary site of thrombopoiesis 2023 ·Blood ·(unknown), Estelle Carminita, Virginia Camacho, (unknown), David Stegner, (unknown), Isabelle C. Becker, Kellie R. Machlus, Abdullah O. Khan, Joseph E. Italiano	30
6	Antibody-mediated depletion of human CLEC-2 in a novel humanized mouse model 2023 ·Blood Advances ·(unknown), Sarah Beck, (unknown), Ying Di, (unknown), (unknown), Steven G. Thomas, Valbona Mirakaj, Steve P. Watson, Bernhard Nieswandt, David Stegner	4
7	Divalent nanobodies to platelet CLEC-2 can serve as agonists or antagonists 2023 ·Communications Biology ·(unknown), (unknown), (unknown), Ying Di, Xueqing Wang, Malou Zuidscherwoude, (unknown), Deirdre M. Kavanagh, Johan Hummert, Johannes A. Eble, Bernhard Nieswandt, David Stegner, Alice Y. Pollitt, Dirk‐Peter Herten, Michael G. Tomlinson, Ángel Galindo García, Steve P. Watson	6
8	OC 47.5 Platelet-Derived Integrin and Tetraspanin-Enriched Tethers (PITTs) Orchestrate Neutrophil Recruitment and Drive Pulmonary Thrombo-Inflammation 2023 ·Research and Practice in Thrombosis and Haemostasis ·David Johnson, (unknown), Philipp Burkard, Mara Meub, Paquita Nurden, Carina Gross, Linnea A. Weiss, Markus Bender, Timo Vögtle, Dirk Weismann, Wolfgang Kastenmüller, Peter Rosenberger, Harald Schulze, (unknown), Markus Sauer, David Stegner, Alan T. Nurden, Bernhard Nieswandt	1
9	OC 49.5 Platelet-Derived LTB4 Mediates Neutrophil Recruitment 2023 ·Research and Practice in Thrombosis and Haemostasis ·Carsten Hackenbroch, Carina Gross, Tolga Çimen, (unknown), Sarah Beck, Tamara Girbl, Robert Ahrends, David Stegner	1
10	Role of Tyrosine Kinase Syk in Thrombus Stabilisation at High Shear 2022 ·International Journal of Molecular Sciences ·Gina Perrella, Samantha J. Montague, (unknown), (unknown), Alexandre Slater, David Stegner, Mark R. Thomas, Johan W. M. Heemskerk, Steve P. Watson	8
11	Experimental validation of computerised models of clustering of platelet glycoprotein receptors that signal via tandem SH2 domain proteins 2022 ·PLoS Computational Biology ·(unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Jeremy A. Pike, Ying Di, Natalie S. Poulter, Alexandre Slater, Bodo Lange, Bernhard Nieswandt, Johannes A. Eble, Michael G. Tomlinson, Dylan M. Owen, David Stegner, Lloyd Bridge, Christoph Wierling, Steve P. Watson	4
12	Generation of a humanized FXII knock‐in mouse—A powerful model system to test novel anti‐thrombotic agents 2021 ·Journal of Thrombosis and Haemostasis ·Sarah Beck, David Stegner, Stefan Loroch, Ayesha Baig, (unknown), (unknown), (unknown), Albert Sickmann, Frauke May, Marc W. Nolte, Con Panousis, Bernhard Nieswandt	2
13	ADAP deficiency impairs megakaryocyte polarization with ectopic proplatelet release and causes microthrombocytopenia 2018 ·Blood ·(unknown), Judith M.M. van Eeuwijk, (unknown), Paquita Nurden, Bernhard Nieswandt, David Stegner, Annegret Reinhold, Markus Bender	31
14	Thrombopoiesis is spatially regulated by the bone marrow vasculature 2017 ·Nature Communications ·David Stegner, (unknown), Oğuzhan Angay, (unknown), (unknown), Jürgen Pinnecker, (unknown), Imke Meyer, Mike Friedrich, Sebastian Dütting, Christian Brede, Andreas Beilhack, Harald Schulze, Bernhard Nieswandt, Katrin G. Heinze	92
15	Congenital valvular defects associated with deleterious mutations in the PLD1 gene 2016 ·Journal of Medical Genetics ·Asaf Ta‐Shma, Kai Zhang, Ekaterina Salimova, Alma Zernecke, (unknown), David Stegner, Milena B. Furtado, Avraham Shaag, Zeev Perles, Bernhard Nieswandt, Azaria J.J.T. Rein, Nadia Rosenthal, Aaron M. Neiman, Orly Elpeleg	30
16	GPVI and Thromboxane Receptor on Platelets Promote Proinflammatory Macrophage Phenotypes during Cutaneous Inflammation 2016 ·Journal of Investigative Dermatology ·Sandra Pierre, Bona Linke, J. Suo, (unknown), Domenico Del Turco, Dominique Thomas, Nerea Ferreirós, David Stegner, (unknown), Marco Sisignano, Sascha Meyer dos Santos, Natasja de Bruin, Rolf M. Nüsing, Thomas Deller, Bernhard Nieswandt, Gerd Geißlinger, Klaus Scholich	54
17	Phospholipase D1 facilitates second-phase myoblast fusion and skeletal muscle regeneration 2014 ·Molecular Biology of the Cell ·(unknown), David Stegner, Qin Chen, Tsunaki Hongu, Hiroshi Hasegawa, Li Chen, Yasunori Kanaho, Bernhard Nieswandt, Michael A. Frohman, Ping Huang	18
18	Gray platelet syndrome and defective thrombo-inflammation in Nbeal2-deficient mice 2013 ·Journal of Clinical Investigation ·Carsten Deppermann, Deya Cherpokova, Paquita Nurden, Jan-Niklas Schulz, Ina Thielmann, Peter Kraft, Timo Vögtle, Christoph Kleinschnitz, Sebastian Dütting, Georg Krohne, Sabine A. Eming, Alan T. Nurden, Beate Eckes, Guido Stoll, David Stegner, Bernhard Nieswandt	139
19	Differentially regulated GPVI ectodomain shedding by multiple platelet–expressed proteinases 2010 ·Blood ·Markus Bender, Sebastian Hofmann, David Stegner, Athena Chalaris, Michael R. Bösl, Attila Braun, Jürgen Scheller, Stefan Rose‐John, Bernhard Nieswandt	98
20	Stromal Interaction Molecules 1 and 2 Are Key Regulators of Autoreactive T Cell Activation in Murine Autoimmune Central Nervous System Inflammation 2009 ·The Journal of Immunology ·Michael K. Schuhmann, David Stegner, Alejandro Berna‐Erro, Stefan Bittner, Attila Braun, Christoph Kleinschnitz, Guido Stoll, Heinz Wiendl, Sven G. Meuth, Bernhard Nieswandt	89

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact